Key facts
- Notable investors include Suzhou Oriza Holdings Corporation, China Growth Capital, Nanjing Jiangbei New Area Science and Technology Investment Group, Noah Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Wemass Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Wemass Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wemass Medical
Developer of implantable drug delivery device for medical use. The company focuses on the research and development and application of new technologies for minimally invasive implantable drug delivery devices (PORT), mainly including interventional access + implantable intelligent interventional products.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Wemass Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wemass Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wemass Medical in its N-PORT filings yet. We sweep new filings monthly.